StreetAlpha.app
Home › Stocks › GKOS

GLAUKOS Corp (GKOS)

Healthcare
$237.31
▼ −0.33%
LAST CLOSE · NOV 20

Glaukos develops and sells eye treatments, including glaucoma stents and drug implants, for ophthalmologists and other eye care professionals. It last closed at $237.31 on Nov 20, down 0.33% on the day. The next earnings report for GKOS is expected around Tue, Jan 12, 2027, after the close. For the quarter ended Sep 2026, GKOS reported EPS of $0.03 on revenue of $211.0M, with revenue up 58.0% from a year ago. Over its last 8 reports the stock moved an average of 14.1% the session after earnings. Over the last 12 months GKOS insiders bought $0 of stock on the open market and sold $136.3M, according to SEC Form 4 filings.

AI Auto Pilots
Is GKOS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GKOS.

Key Stats

Last 12 months
Results
Revenue
$690.3M
+46.9% vs a year ago
Net income
−$169.8M
−24.6% margin
EPS (diluted)
−$2.95
Free cash flow
$36.0M
5.2% margin
Valuation
Market cap
$14.0B
59.2M shares
P/E
–
No P/E while losing money
Price to sales
20.3
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$162.3M
At Sep 30
Shareholder equity
$717.3M
Shares outstanding
59.2M
At Oct 26
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $294.0M$294.0MFY2021FY2022: $282.9M$282.9MFY2022FY2023: $314.7M$314.7MFY2023FY2024: $383.5M$383.5MFY2024FY2025: $507.4M$507.4MFY2025

From GKOS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.

Next report
Jan 12
Estimated date · After the close
Reported EPS
$0.03
Quarter ended Sep 2026
Year ago EPS
-$0.28
Same quarter last year
Revenue
$211.0M
+58.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.59Dec '24Mar 2025: -$0.32Mar '25Jun 2025: -$0.34Jun '25Sep 2025: -$0.28Sep '25Dec 2025: -$2.33Dec '25Mar 2026: -$0.34Mar '26Jun 2026: -$0.31Jun '26Sep 2026: $0.03Sep '26Latest $0.03
Revenue by quarter
Dec 2024: $105.5MDec '24Mar 2025: $106.7MMar '25Jun 2025: $124.1MJun '25Sep 2025: $133.5MSep '25Dec 2025: $143.1MDec '25Mar 2026: $150.6MMar '26Jun 2026: $185.6MJun '26Sep 2026: $211.0MSep '26Latest $211.0M
How GKOS moved after its last 8 reports
Average move the session after a report ±14.1%
Oct 28, 2026After the close+33.6%
Jul 29, 2026After the close+4.2%
Apr 29, 2026After the close+22.8%
Feb 17, 2026After the close+13.5%
Jan 13, 2026After the close−5.3%
Oct 29, 2025After the close+13.9%
Jul 30, 2025After the close−8.5%
Apr 30, 2025After the close−11.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on GKOSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on GKOS
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on GKOS

Technical Analysis

GKOS · as of the Nov 20 close · updated each morning
Uptrend

The stock is 3% above its 20 day and 20% above its 50 day average. It is 37% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 61). The nearest support is the Pivot S1 at $232.29, and the nearest resistance the Pivot at $238.42.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 4.8%/day
Key levels
$255.1952 week high+7.5%
$250.61Swing high (Nov 16)+5.6%
$243.44Pivot R1+2.6%
$238.42Pivot+0.5%
$237.31Last close
$232.29Pivot S1−2.1%
$229.7120 day average−3.2%
$218.76Swing low (Nov 5)−7.8%
$190.9550 day average−19.5%
$180.19100 day average−24.1%
$150.33200 day average−36.7%
$93.7852 week low−60.5%
Indicators
RSI (14)61.16Strong, overbought above 70Neutral
MACD14.81Below its signal lineBearish
Stochastic47.8Middle of its rangeNeutral
ADX (14)41.4Strong uptrend
Williams %R-49.1Oversold below −80, overbought above −20Neutral
CCI (20)37.4Oversold below −100, overbought above 100Neutral
Rate of change+5.8%Change over 10 sessionsBullish
ATR (14)$11.37Typical daily range, 4.8% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for GKOS

What happened before

See how GKOS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow GKOS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How GKOS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for GKOSHow many large options trades hit GKOS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

GKOS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲230 buying vs 177 selling
  • ▼Held by funds -2.4 pts
  • ▲Funds holding +53
  • ▲Superinvestors: 3 added, 2 cut
  • ▼Put/call 2.12 to 2.67
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding422369+14.4%
In funds' top 1052+150.0%
Held by funds100.3%102.7%−2.4 pts
New / increased89 / 14168 / 146+7.5%
Reduced / sold out141 / 36102 / 39+25.5%
Put/call ratio2.672.12+25.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GKOS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

GKOS Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$136.3M36 sales · 8 insiders
77% of the selling was under pre-arranged trading plans.
2025-12 sold $536K2026-01 sold $35.4M2026-02 sold $1.8M2026-03 sold $590K2026-04 sold $1.6M2026-05 sold $4.4M2026-06 sold $201K2026-07 sold $4.8M2026-08 sold $17.3M2026-09 sold $492K2026-10 sold $10.9M2026-11 sold $58.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 18Alex R. ThurmanSVP & CFOSale plan15,000$236.92$3.6M
Nov 18Thomas William BurnsChairman & CEOSale plan180,000$236.89$42.6M
Nov 16Joseph E GilliamPresident & COOSale plan861$250.00$215K
Nov 12Joseph E GilliamPresident & COOSale plan44,917$246.32$11.1M
Nov 4Gilbert H KlimanDirectorSale2,500$253.00$633K
Oct 30Tomas NavratilChief Development OfficerSale44,436$238.97$10.6M
Every insider buy and sale for GKOS over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See GKOS insider trades →

From SEC Form 4 filings by GKOS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GKOS is in one of them and how their past GKOS trades turned out.

GKOS in the AI portfolios
Loading…

GKOS News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GKOS in an article yet. Here's the latest on the wider market.

GKOS in the news

About GLAUKOS

Glaukos is an ophthalmic pharmaceutical and medical technology company based in Aliso Viejo, California. It makes procedural treatments for glaucoma, including small stents placed during eye surgery and a drug implant that releases medication inside the eye over time. It also sells treatments that strengthen the cornea for corneal disorders such as keratoconus, and it is developing therapies for retinal disease. Its customers are ophthalmologists and other eye care professionals.

Headquarters
Aliso Viejo, CA